• 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

  • Jul 12 2024
  • Duración: 20 m
  • Podcast

119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.


    In this episode, Sameea Husain-Wilson, DO, a movement disorder specialist at the Marcus Neuroscience Institute of Baptist Health, provided clinical perspective on the use of the Syn-One diagnostic test for patients with Parkinson disease (PD). She gave an overview of how the test is utilized in clinic, ways to interpret results, and the right personnel needed to ensure an accurate diagnosis. In addition, she provided clarity on the role of alpha-synuclein in PD, the advances in research in this area, and how the test incorporates this prominent biomarker. Furthermore, Husain-Wilson detailed some of the next steps in further optimizing the test in clinical settings, highlighting the importance of other non-movement disorder specialists who will play a major role in the diagnostic evaluation of future patients with PD.


    Looking for more movement disorder discussion? Check out the NeurologyLive® movement disorder clinical focus page.

    Episode Breakdown:
    • 1:10 – Step by step process on how Syn-One test is used; considerations after process is done
    • 3:15 – How the test differentiates PD from other neurodegenerative disorders
    • 9:50 – Neurology News Minute
    • 12:20 – Value and role in assessing alpha-synuclein in PD
    • 14:50 – Ways to further optimize Syn-One going forward

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • FDA Approves Eli Lilly's Donanemab for Early Symptomatic Alzheimer Disease
    • Buntanetap Improves Motor, Nonmotor and Cognitive Symptoms of Parkinson Disease in Phase 3 Study
    • Gene Therapy AMT-130 Slows Huntington Disease Progression in Interim Phase 1/2 Trials

    Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
    Más Menos
Enfermedades Físicas Hygiene & Healthy Living Ciencia
Más Menos

Lo que los oyentes dicen sobre 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles